$ Value
$0
Shares
55,309
Price
$0
Filed
Dec 2
Insider
Name
Dugan Margaret
Title
Chief Medical Officer
CIK
0001909734
Roles
Transaction Details
Transaction Date
2025-12-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
55,309
Footnotes
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 1, 2025. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 1, 2025.
Filing Info
Dugan Margaret's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | WHWK | A | $0 |
| 2025-12-01 | WHWK | A | $0 |
| 2025-12-01 | WHWK | A | $0 |
| 2025-10-16 | SDGR | ▼ | $29K |
| 2025-05-21 | BGNE | A | $0 |
| 2025-05-21 | BGNE | A | $0 |
Other Insiders at WHWK (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
|
— | $882K | 2026-04-16 |
|
BALL BRYAN
See remarks
|
— | $635K | 2026-04-14 |
|
Dornan David
Chief Scientific Officer
|
— | — | 2026-04-01 |
|
Dugan Margaret
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Lennon David James
CHIEF EXECUTIVE OFFICER
|
— | $1.0M | 2026-04-09 |